Filing Details

Accession Number:
0001178913-22-001179
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-03-21 06:02:52
Reporting Period:
2022-03-14
Accepted Time:
2022-03-21 06:02:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1534248 Chemomab Therapeutics Ltd. CMMB Pharmaceutical Preparations (2834) 813676773
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1891264 Donald Marvin 2094 Lost Canyon Ranch Ct
Castle Rock CO 80104
Executive Vp, Cfo & Coo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
American Depositary Shares Acquisiton 2022-03-14 250 $4.00 250 No 4 P Direct
American Depositary Shares Acquisiton 2022-03-14 250 $3.98 500 No 4 P Direct
American Depositary Shares Acquisiton 2022-03-14 250 $3.90 1,000 No 4 P Direct
American Depositary Shares Acquisiton 2022-03-14 250 $4.10 1,250 No 4 P Direct
American Depositary Shares Acquisiton 2022-03-14 250 $4.20 1,500 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
American Depositary Shares Option to Purchase American Depositary Shares Acquisiton 2021-11-08 196,875 $0.00 196,875 $9.77
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
196,875 2021-11-08 No 4 A Direct
Footnotes
  1. Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
  2. No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
  3. The options vest and become exercisable over a period of four (4) years, with one quarter (1/4) of the options vesting on November 8, 2022 -- the first anniversary of the grant date -- and the remainder in equal amounts over the ensuing 36 monthly periods, subject to the Reporting Person's continued service.